Prenetics CIRCLE
People who want to know their inherited cancer risk
Prices verified Aug 13, 2026 on Prenetics CIRCLE's own site
Test Performance
Sensitivity
Variable
Specificity
Variable
Detection Method
Whole-exome sequencing (germline DNA)
Turnaround
18 business days
Key Features
Direct to consumer • Whole-exome saliva test • Inherited risk across 35+ cancers • Does not detect existing cancer
Who It's For
Suited to: People who want to know their inherited cancer risk
Not suited to: Anyone looking for a test that detects cancer now
Important Notes
IMPORTANT: this is a hereditary risk test, not active cancer detection. CircleDNA is a consumer whole-exome saliva test whose Cancer Screening Report assesses inherited predisposition across 35+ cancers - it does not detect existing cancer. Hong Kong based (Prenetics Global, NASDAQ: PRE); pricing is served in HKD and varies by region. Prenetics' actual blood-based multi-cancer test is Presight, via the Insighta joint venture with Prof. Dennis Lo (lung and liver today; Presight One for 10+ cancers targeted for 2027).
Learn more about Prenetics CIRCLE
Discuss with your physician before ordering.
Visit Prenetics CIRCLECompare All